Comparison of acute and chronic glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, and metformin, in rat models of type 2 diabetes

被引：0
|
作者：
Yoshida, Taishi
Takahashi, Kanako
Nakashima, Ryutaro
Kanda, Shoichi
Okuno, Akira
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 47 条
  • [31] Glimepiride Strongly Enhances the Glucose-Lowering Effect in Triple Oral Antidiabetes Therapy with Sitagliptin and Metformin for Japanese Patients with Type 2 Diabetes Mellitus
    Arai, Keiko
    Maeda, Hajime
    Sirabe, Sin-ichiro
    Yamamoto, Ritsuko
    Yamauchi, Mikio
    Hirao, Tetsuyuki
    Hirao, Setsuko
    Hirao, Koichi
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (04) : 335 - 341
  • [32] Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes
    Kim, Tae-Hyoung
    Kim, Mi-Kyung
    Cheong, Ye-Hwang
    Chae, Yu-Na
    Lee, Youngyi
    Ka, Sun-O
    Jung, Il-Hoon
    Shin, Chang-Yell
    Bae, Eun Ju
    Son, Moon-Ho
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 771 : 65 - 76
  • [33] Enhanced glucose-lowering effect of dipeptidyl peptidase-4 inhibitor in subjects with type 2 diabetes who have a history of gastrectomy
    Wada, Y.
    Hamamoto, Y.
    Honjo, S.
    Fujimoto, K.
    Tatsuoka, H.
    Matsuoka, A.
    Ikeda, H.
    Fujikawa, J.
    Koshiyama, H.
    DIABETOLOGIA, 2014, 57 : S359 - S360
  • [34] The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1
    Nerild, H. H.
    Bronden, A.
    Haddouchi, A. E.
    Holst, J. J.
    Sonne, D. P.
    Vilsboll, T.
    Knop, F. K.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 217 - 217
  • [35] Polymophism of OCT2 and MATE1 improve glucose-lowering effect of metformin via influencing its pharmacokinetics in Chinese type 2 diabetic patients
    Hou, W. L.
    Zhang, D. D.
    Lu, W.
    Zheng, T. S.
    Wan, L. L.
    Li, Q.
    Liu, F.
    Jia, W. P.
    DIABETOLOGIA, 2014, 57 : S318 - S319
  • [36] SLC47A1 gene rs2289669 G > A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients
    He, Rui
    Zhang, Dandan
    Lu, Wei
    Zheng, Taishan
    Wan, Lili
    Liu, Fang
    Jia, Weiping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (01) : 57 - 63
  • [37] Glucose-lowering effects of 7-day treatment with SGLT2 inhibitor confirmed by intermittently scanned continuous glucose monitoring in outpatients with type 1 diabetes. A pilot study
    Kurozumi, Akira
    Okada, Yosuke
    Tanaka, Yoshiya
    ENDOCRINE JOURNAL, 2021, 68 (03) : 361 - 369
  • [38] Deterioration of HbA1c-Lowering Effects in Dipeptidyl-Peptidase Inhibitor and Dietary Habits in Japanese Type 2 Diabetes-Comparison with That of Metformin
    Okamoto, Saki
    Kuwata, Hitoshi
    Yabe, Daisuke
    Murotani, Kenta
    Seino, Yusuke
    Usui, Ryota
    Tatsuoka, Hisato
    Hamamoto, Yoshiyuki
    Kurose, Takeshi
    Seino, Yutaka
    DIABETES, 2018, 67
  • [39] SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose-lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review
    Escobar, Carlos
    Barrios, Vivencio
    Cosin, Juan
    Gamez Martinez, Jose Maria
    Huelmos Rodrigo, Ana Isabel
    Ortiz Cortes, Carolina
    Torres Llergo, Javier
    Requeijo, Carolina
    Sola, Ivan
    Martinez Zapata, M. Jose
    DIABETIC MEDICINE, 2021, 38 (03)
  • [40] Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents
    Atsushi Tanaka
    Shigeru Toyoda
    Takumi Imai
    Kazuki Shiina
    Hirofumi Tomiyama
    Yasushi Matsuzawa
    Takahiro Okumura
    Yumiko Kanzaki
    Katsuya Onishi
    Arihiro Kiyosue
    Masami Nishino
    Yasushi Sakata
    Koichi Node
    Cardiovascular Diabetology, 20
12345